GlaxoSmithKline ( GlaxoSmithKline )
Management of GlaxoSmithKline
Philip Hampton is the chairman of the company. He was born on October 5, 1953. He gained an MA in English from Lincoln College, Oxford, in 1975. He joined the accounting firm Coopers & Lybrand the same year, qualified as a chartered accountant in 1978, and then trained as an auditor. Emma Walmsley is the CEO of the company. She was born in June 1969 in Barrow-in-Furness in Lancashire.
980 Great West Rd, Brentford, London, United Kingdom
GlaxoSmithKline plc (GSK) is a British pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi. Emma Walmsley became CEO on 31 March 2017 and is the first female CEO of the company. The GlaxoSmithKline has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of August 2016 it had a market capitalisation of £81 billion (around $107 billion), the fourth largest on the London Stock Exchange. It has a secondary listing on the New York Stock Exchange.